British Columbia's Supreme Court deals blow to Wyeth on HRT case
This article was originally published in Scrip
Executive Summary
Wyethis far from over with litigation in the US over its hormone replacement therapies, and now it has been unable to block a British Columbia lawsuit, clearing the way for a possible class action in Canada that alleges that the company's HRT products cause breast cancer. In Canada, the products are known as Premarin and Premplus, while in the US multidistrict litigation concerns Premarin and Prempro.